Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3289067
Max Phase: Preclinical
Molecular Formula: C32H46N2O2
Molecular Weight: 490.73
Molecule Type: Small molecule
Associated Items:
ID: ALA3289067
Max Phase: Preclinical
Molecular Formula: C32H46N2O2
Molecular Weight: 490.73
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C[C@H]1[C@H](C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)Cc6cncnc6C(C)(C)[C@@H]5CC[C@]43C)[C@H]12
Standard InChI: InChI=1S/C32H46N2O2/c1-19-10-13-32(27(35)36)15-14-30(6)22(25(32)20(19)2)8-9-24-29(5)16-21-17-33-18-34-26(21)28(3,4)23(29)11-12-31(24,30)7/h8,17-20,23-25H,9-16H2,1-7H3,(H,35,36)/t19-,20+,23+,24-,25+,29+,30-,31-,32+/m1/s1
Standard InChI Key: ZHOJOWDMKNKGJV-ZJFKBAMLSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 490.73 | Molecular Weight (Monoisotopic): 490.3559 | AlogP: 7.23 | #Rotatable Bonds: 1 |
Polar Surface Area: 63.08 | Molecular Species: ACID | HBA: 3 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 4.71 | CX Basic pKa: 1.90 | CX LogP: 7.03 | CX LogD: 4.40 |
Aromatic Rings: 1 | Heavy Atoms: 36 | QED Weighted: 0.42 | Np Likeness Score: 2.50 |
1. Fu HJ, Zhou YR, Bao BH, Jia MX, Zhao Y, Zhang L, Li JX, He HL, Zhou XM.. (2014) Tryptophan hydroxylase 1 (Tph-1)-targeted bone anabolic agents for osteoporosis., 57 (11): [PMID:24844139] [10.1021/jm5002293] |
Source(1):